Search

everythinglearnresearchcommunity

for

Search:↓

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

The new drug delivery system effectively targets lung cancer cells.

The prototype for analyzing skin aging works technically and clinically.

TAK-279 effectively reduces psoriasis symptoms and is safe.

MK-5108 is safe and shows potential against tumors, especially alone.

TOF-SIMS improved chemical mapping in cells, confirming gunshot residue, tracking anti-tumor drugs, and identifying molecules in mosquitoes and wounds.

The LTF gene may help predict and manage nonspecific orbital inflammation.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

The hydrogel effectively treats oral mucositis by reducing oxidative damage and bacterial infection.

Certain gene changes in osteopontin are linked to higher risk of atopic dermatitis and asthma.

Improved delivery systems can enhance oleanolic acid's effectiveness in treating various conditions.

SIG-1451 could be a promising new treatment for atopic dermatitis.

OR2AT4 helps reduce aging and cell damage in human skin cells.

The TT genotype of a specific SNP in sheep is linked to better wool quality.

South African wild foods may help prevent cardiovascular disease.

RTA 408 cream protects mice from radiation skin damage.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Tofacitinib is a promising treatment for children with rheumatic diseases.

The combined treatment effectively managed severe skin issues in Olmsted syndrome.

Mutants of CYP154C2 enzyme significantly improved steroid conversion efficiency.

ODAC members faced intense pressure but prioritized scientific evidence in drug approval decisions.

Nanocarriers with spironolactone and 2-deoxy-D-ribose may improve hair loss treatment by targeting hair follicles directly.